--- Query Results --- | |||
| Organization: | Alberta Precision Laboratories | ||
| Test Name/Synonym: | Sulfonylurea Screen (Synonym: Hypoglycemic Agent, Hypoglycemic Screen, Glyburide, Repaglinide Related Compound, Gliclazide Related Compounds, Tolbutamide, Chlorpropamide) | ||
| Test Includes: | Glyburide Repaglinide related compound Gliclazide related compounds Tolbutamide Chlorpropamide | ||
| LABID (Connect Care): | LAB123000485 | ||
| Specimen Type: | Blood preferred; urine acceptable | ||
| Primary Container: | RED | ||
| Alternate Containers: | Urine: STERILE URINE CUP W/ORANGE LID | ||
| Minimum Collection Volume: | 5 mL serum or 10 mL urine | ||
| Specimen Collection Requirements: | Serum is the preferred specimen type. However, a spot urine collection will also be accepted. Urine must be collected in Starplex LeakbusterTM sterile urine cup (transparent body) with orange lid. Do not collect in same container with other urine tests. 60 mL container size is preferred. Alternate container types have not been validated and will not be accepted (including Becton Dickinson ® aliquot tubes, white lidded or pink lidded containers, orange lidded opaque containers). | ||
| Stability and Storage: | 14 days refrigerated (serum or urine) | ||
| Processing: | Blood: Centrifuge and aliquot | ||
| Testing Schedule: | Test completed within 2 weeks of receipt of sample | ||
| Testing Area: | Toxicology | ||
| Performing Site: | University of Alberta Hospital | ||
| Last Updated On: | Tuesday, April 15, 2025 | ||
| Registered Trademark Comments: | LeakbusterTM is a registered trademark of Starplex Scientific Inc. | ||
